Fernando Tobias Silveira, Gabriela V Araujo Flores, Carmen Maria S Pacheco, Wilfredo Sosa-Ochoa, Thiago Vasconcelos Dos Santos, Edivaldo Costa Sousa, Concepción Zúniga Valeriano, Vania Lucia da Matta, Claudia Maria C Gomes, Patrícia Karla Ramos, Luciana Vieira Lima, Marliane Batista Campos, Carlos Eduardo P Corbett, Márcia Dalastra Laurenti
{"title":"利什曼原虫(Leishmania) poncei n. sp.(活动体:锥虫科)的综合表型和基因型分类综述:中美洲洪都拉斯皮肤(非溃烂)和内脏利什曼病的一种新型病原体。","authors":"Fernando Tobias Silveira, Gabriela V Araujo Flores, Carmen Maria S Pacheco, Wilfredo Sosa-Ochoa, Thiago Vasconcelos Dos Santos, Edivaldo Costa Sousa, Concepción Zúniga Valeriano, Vania Lucia da Matta, Claudia Maria C Gomes, Patrícia Karla Ramos, Luciana Vieira Lima, Marliane Batista Campos, Carlos Eduardo P Corbett, Márcia Dalastra Laurenti","doi":"10.1186/s40794-025-00264-1","DOIUrl":null,"url":null,"abstract":"<p><p>Non-ulcerated cutaneous leishmaniasis (NUCL) is an atypical clinical form of leishmaniasis first described, in 1988, by Ponce and collaborators, in Honduras, Central America, characterized by isolated or disseminated closed skin lesions appearing as papules, nodules, or infiltrated plaques, primarily in adolescents and young adults. Leishmania (L.) chagasi was then identified as the causal agent of both NUCL and American visceral leishmaniasis (AVL) in Honduras, though NUCL has been reported as more prevalent. However, due to the uncertain taxonomic classification of the NUCL-causing parasite, especially since L. (L.) chagasi has not been associated to this form of the disease in South America, this study conducted a comprehensive taxonomic review incorporating phenotypic (biological and clinical-immunopathological) and genotypic (genomic/molecular) analyses. Biologically, Honduran parasite-LPG does not have Gal (β1,4) Man (α1)-PO4 side chains common to all Leishmania LPGs. From a clinical-pathogenic perspective, NUCL is unique, it does not ulcerate like cutaneous leishmaniasis due to L. (L.) chagasi or L. (L.) infantum. Molecular findings showed that the Honduran parasite is more ancestral than all known viscerotropic Leishmania species, exhibited an unprecedented structural variation on chromosome 17 with the highest frequency of genomic SNPs, formed a distinct phylogenetic lineage, and displayed a homozygous SNP profile typical of a parental (non-hybrid) parasite. Building on these findings, a new species, Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae), is proposed in honor of Professor Carlos Ponce, who first described NUCL in Honduras. This study formally classifies L. (L.) poncei n. sp. as a novel Leishmania species responsible for both NUCL and AVL in Honduras, Central America.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"27"},"PeriodicalIF":2.2000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12302823/pdf/","citationCount":"0","resultStr":"{\"title\":\"A comprehensive phenotypic and genotypic taxonomic review of Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae): a novel agent of cutaneous (non-ulcerated) and visceral leishmaniasis in Honduras, Central America.\",\"authors\":\"Fernando Tobias Silveira, Gabriela V Araujo Flores, Carmen Maria S Pacheco, Wilfredo Sosa-Ochoa, Thiago Vasconcelos Dos Santos, Edivaldo Costa Sousa, Concepción Zúniga Valeriano, Vania Lucia da Matta, Claudia Maria C Gomes, Patrícia Karla Ramos, Luciana Vieira Lima, Marliane Batista Campos, Carlos Eduardo P Corbett, Márcia Dalastra Laurenti\",\"doi\":\"10.1186/s40794-025-00264-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Non-ulcerated cutaneous leishmaniasis (NUCL) is an atypical clinical form of leishmaniasis first described, in 1988, by Ponce and collaborators, in Honduras, Central America, characterized by isolated or disseminated closed skin lesions appearing as papules, nodules, or infiltrated plaques, primarily in adolescents and young adults. Leishmania (L.) chagasi was then identified as the causal agent of both NUCL and American visceral leishmaniasis (AVL) in Honduras, though NUCL has been reported as more prevalent. However, due to the uncertain taxonomic classification of the NUCL-causing parasite, especially since L. (L.) chagasi has not been associated to this form of the disease in South America, this study conducted a comprehensive taxonomic review incorporating phenotypic (biological and clinical-immunopathological) and genotypic (genomic/molecular) analyses. Biologically, Honduran parasite-LPG does not have Gal (β1,4) Man (α1)-PO4 side chains common to all Leishmania LPGs. From a clinical-pathogenic perspective, NUCL is unique, it does not ulcerate like cutaneous leishmaniasis due to L. (L.) chagasi or L. (L.) infantum. Molecular findings showed that the Honduran parasite is more ancestral than all known viscerotropic Leishmania species, exhibited an unprecedented structural variation on chromosome 17 with the highest frequency of genomic SNPs, formed a distinct phylogenetic lineage, and displayed a homozygous SNP profile typical of a parental (non-hybrid) parasite. Building on these findings, a new species, Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae), is proposed in honor of Professor Carlos Ponce, who first described NUCL in Honduras. This study formally classifies L. (L.) poncei n. sp. as a novel Leishmania species responsible for both NUCL and AVL in Honduras, Central America.</p>\",\"PeriodicalId\":23303,\"journal\":{\"name\":\"Tropical Diseases, Travel Medicine and Vaccines\",\"volume\":\"11 1\",\"pages\":\"27\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-07-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12302823/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tropical Diseases, Travel Medicine and Vaccines\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s40794-025-00264-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tropical Diseases, Travel Medicine and Vaccines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40794-025-00264-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
非溃疡性皮肤利什曼病(NUCL)是一种非典型临床形式的利什曼病,于1988年由Ponce及其合作者在中美洲洪都拉斯首次描述,其特征是孤立或弥散性闭合皮肤病变,表现为丘疹、结节或浸润性斑块,主要发生在青少年和年轻人中。随后,查加西利什曼原虫(L. chagasi)被确定为NUCL和洪都拉斯美国内脏利什曼病(AVL)的致病因子,尽管据报道NUCL更为普遍。然而,由于引起nucl的寄生虫的分类分类不确定,特别是由于南美的这种形式的疾病没有与L. (L.) chagasi相关,本研究进行了全面的分类回顾,包括表型(生物学和临床免疫病理)和基因型(基因组/分子)分析。从生物学上讲,洪都拉斯寄生虫lpg不具有所有利什曼原虫lpg共有的Gal (β1,4) Man (α1)-PO4侧链。从临床致病性的角度来看,NUCL是独特的,它不像皮肤利什曼病那样由L. (L.) chagasi或L. (L.) inftum引起溃疡。分子研究结果表明,洪都拉斯寄生虫比所有已知的嗜内脏利什曼原虫更古老,在第17号染色体上表现出前所未有的结构变异,基因组SNP频率最高,形成了独特的系统发育谱系,并表现出典型的亲本(非杂交)寄生虫的纯合SNP谱。在这些发现的基础上,提出了一个新的物种,利什曼原虫(利什曼原虫)poncei n. sp. (Kinetoplastea:锥虫科),以纪念Carlos Ponce教授,他首先在洪都拉斯描述了NUCL。本研究将L. (L.) poncei n. sp.正式归类为在中美洲洪都拉斯造成NUCL和AVL的一种新型利什曼原虫。
A comprehensive phenotypic and genotypic taxonomic review of Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae): a novel agent of cutaneous (non-ulcerated) and visceral leishmaniasis in Honduras, Central America.
Non-ulcerated cutaneous leishmaniasis (NUCL) is an atypical clinical form of leishmaniasis first described, in 1988, by Ponce and collaborators, in Honduras, Central America, characterized by isolated or disseminated closed skin lesions appearing as papules, nodules, or infiltrated plaques, primarily in adolescents and young adults. Leishmania (L.) chagasi was then identified as the causal agent of both NUCL and American visceral leishmaniasis (AVL) in Honduras, though NUCL has been reported as more prevalent. However, due to the uncertain taxonomic classification of the NUCL-causing parasite, especially since L. (L.) chagasi has not been associated to this form of the disease in South America, this study conducted a comprehensive taxonomic review incorporating phenotypic (biological and clinical-immunopathological) and genotypic (genomic/molecular) analyses. Biologically, Honduran parasite-LPG does not have Gal (β1,4) Man (α1)-PO4 side chains common to all Leishmania LPGs. From a clinical-pathogenic perspective, NUCL is unique, it does not ulcerate like cutaneous leishmaniasis due to L. (L.) chagasi or L. (L.) infantum. Molecular findings showed that the Honduran parasite is more ancestral than all known viscerotropic Leishmania species, exhibited an unprecedented structural variation on chromosome 17 with the highest frequency of genomic SNPs, formed a distinct phylogenetic lineage, and displayed a homozygous SNP profile typical of a parental (non-hybrid) parasite. Building on these findings, a new species, Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae), is proposed in honor of Professor Carlos Ponce, who first described NUCL in Honduras. This study formally classifies L. (L.) poncei n. sp. as a novel Leishmania species responsible for both NUCL and AVL in Honduras, Central America.
期刊介绍:
Tropical Diseases, Travel Medicine and Vaccines is an open access journal that considers basic, translational and applied research, as well as reviews and commentary, related to the prevention and management of healthcare and diseases in international travelers. Given the changes in demographic trends of travelers globally, as well as the epidemiological transitions which many countries are experiencing, the journal considers non-infectious problems including chronic disease among target populations of interest as well as infectious diseases.